Examples of using Truberzi in English and their translations into German
{-}
-
Colloquial
-
Official
-
Ecclesiastic
-
Medicine
-
Financial
-
Ecclesiastic
-
Political
-
Computer
-
Programming
-
Official/political
-
Political
How does Truberzi work?
Other information about Truberzi.
How is Truberzi used?
Other medicines and Truberzi.
Why is Truberzi approved?
What are the risks associated with Truberzi?
Truberzi contains the active substance eluxadoline.
Some medicines may increase the level of Truberzi in the blood.
What Truberzi looks like and contents of the pack.
Eluxadoline, the active substance in Truberzi, is an opioid receptor agonist.
Truberzi can only be obtained with a prescription.
All events resolved upon discontinuation of Truberzi, with symptoms typically improved by the following day.
Truberzi may increase the level of some medicines in the blood.
In both studies,the proportion of patients who were composite responders to Truberzi 100 mg twice daily was statistically significantly higher than placebo.
Truberzi is a medicine that acts on the digestive system.
The proportion of patients who were adequate relief responderswas statistically significantly higher than placebo for Truberzi 100 mg twice daily over 6 month interval in both studies.
Truberzi should not be taken whilst pregnant or breast-feeding.
The Agency's Committee for Medicinal Products for Human Use(CHMP) considered that the benefits of Truberzi are modest but there is an unmet need for treatments of irritable bowel syndrome with diarrhoea.
Truberzi was evaluated in two main studies involving over 2,400 patients with irritable bowel syndrome with diarrhoea.
It is unlikely that Truberzi will affect your ability to drive or use tools or machines.
Truberzi should not be given to children and adolescents less than 18 years old as there is no information about its use in this age group.
Truberzi acts on the surface of your gut to restore the normal function of your bowels and block the sensation of pain and discomfort in IBS-D patients.
In both studies Truberzi was compared with placebo(a dummy treatment) over 26 weeks of treatment during which patients kept a daily record of their irritable bowel syndrome symptoms.
Truberzi must not be given to patients treated with a class of medicines known as potent OATP1B1 inhibitors such as ciclosporin, a medicine that works on the immune system.
Truberzi must not be given to patients with liver disorders, those at risk of pancreatitis(such as those who have had problems with their pancreas or who drink alcohol excessively), patients whose gall bladders have been removed or who have disorders affecting secretion of bile into the gut, and those who have had severe or long-term constipation or blocked bowel.